These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 25550338

  • 1. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
    Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K.
    Ann Rheum Dis; 2016 Feb; 75(2):356-61. PubMed ID: 25550338
    [Abstract] [Full Text] [Related]

  • 2. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
    Fisher BA, Bang SY, Chowdhury M, Lee HS, Kim JH, Charles P, Venables P, Bae SC.
    Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
    [Abstract] [Full Text] [Related]

  • 3. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A, Korpela M, Haapala AM, Kautiainen H, Laasonen L, Möttönen T, Leirisalo-Repo M, Ilonen J, Järvenpää S, Luukkainen R, Hannonen P.
    Clin Exp Rheumatol; 2011 Apr; 29(3):500-5. PubMed ID: 21640044
    [Abstract] [Full Text] [Related]

  • 4. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J.
    Lancet; 2009 Aug 08; 374(9688):459-66. PubMed ID: 19665644
    [Abstract] [Full Text] [Related]

  • 5. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA, Neovius M, Nilsson JÅ, Petersson IF, Bratt J, van Vollenhoven RF, Ernestam S, Geborek P.
    Ann Rheum Dis; 2013 Dec 08; 72(12):1927-33. PubMed ID: 23196701
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis.
    Fisher BA, Plant D, Lundberg K, Charles P, Barton A, Venables PJ, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS).
    J Rheumatol; 2012 May 08; 39(5):929-32. PubMed ID: 22467927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, Lundberg K, Engström A, Venables PJ, Toes RE, Holmdahl R, Klareskog L, Malmström V.
    Arthritis Rheum; 2010 Jan 08; 62(1):44-52. PubMed ID: 20039432
    [Abstract] [Full Text] [Related]

  • 10. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK, Hensvold AH, Hansson M, Aga AB, Sexton J, Mathsson-Alm L, Cornillet M, Serre G, Lillegraven S, Fevang BS, Catrina AI, Haavardsholm EA.
    Arthritis Res Ther; 2018 Jul 13; 20(1):146. PubMed ID: 30001740
    [Abstract] [Full Text] [Related]

  • 11. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.
    Arthritis Rheum; 2008 Jan 13; 58(1):36-45. PubMed ID: 18163519
    [Abstract] [Full Text] [Related]

  • 12. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.
    Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, Albertsson K, Forslind K, van Vollenhoven RF, SWEFOT study group.
    Ann Rheum Dis; 2015 Aug 13; 74(8):1509-14. PubMed ID: 24706006
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.
    Levitsky A, Erlandsson MC, van Vollenhoven RF, Bokarewa MI.
    BMC Med; 2015 Sep 30; 13():247. PubMed ID: 26420684
    [Abstract] [Full Text] [Related]

  • 16. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
    van Aken J, Heimans L, Gillet-van Dongen H, Visser K, Ronday HK, Speyer I, Peeters AJ, Huizinga TW, Allaart CF.
    Ann Rheum Dis; 2014 Feb 30; 73(2):396-400. PubMed ID: 23334213
    [Abstract] [Full Text] [Related]

  • 17. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C.
    Rheumatol Int; 2015 Oct 30; 35(10):1693-9. PubMed ID: 25903353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
    Ally MM, Hodkinson B, Meyer PW, Musenge E, Tintinger GR, Tikly M, Anderson R.
    BMC Musculoskelet Disord; 2015 May 29; 16():130. PubMed ID: 26021985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.